Associated Papers
Integrative pharmacogenomics analysis predicts the platelet response in clopidogrel treated coronary artery disease (CAD) patients of South India.
Bharath G et al.
Scientific Reports, 2025
Prioritizing de novo potential non-canonical splicing variants in neurodevelopmental disorders.
Li K et al.
Ebiomedicine, 2024
38113761 (PubMed )
Supplement: mmc2.xlsx › Table_S7
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation.
Baturina O et al.
Pharmacology, 2022
Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients.
Fontana P et al.
Journal of Thrombosis and Haemostasis : Jth, 2020
Beta-1,4-galactosyltransferase 2 c.909C>T gene variant is predictive of on-clopidogrel platelet reactivity.
Pallet N et al.
Pharmacogenomics, 2018
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity.
Scott SA et al.
Clinical Pharmacology and Therapeutics, 2016
Select a paper to view details